Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Nature Cell Biology
|
June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression
Meng Zhang, Martin Sjöström, Xiekui Cui, et al.
Cancer Cell
|
June 28, 2002
Gene expression correlates of clinical prostate cancer behavior
Dinesh Singh, Phillip G Febbo, Kenneth Ross, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 28, 2009
The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model
John C Mavropoulos, W Cooper Buschemeyer, Alok K Tewari, et al.
The Journal of Urology
|
March 11, 2018
A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy
Amirali Salmasi, Jonathan Said, Alan W Shindel, et al.
Urology
|
January 3, 2016
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score
Timothy C Brand, Nan Zhang, Michael R Crager, et al.
European Urology Oncology
|
May 11, 2025
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate Cancer
Nicole Handa, Eric V Li, Jamie Michael, et al.
The EMBO Journal
|
January 7, 2005
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease
Jing Wang, Hiromi Iwasaki, Andrei Krivtsov, et al.
Journal of the National Cancer Institute
|
March 26, 2009
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer
Toshiro Migita, Stacey Ruiz, Alessandro Fornari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2008
NCCN Task Force Report: mTOR inhibition in solid tumors
Robert A Figlin, Elizabeth Brown, Andrew J Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2010
A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer
Andrew J Armstrong, George J Netto, Michelle A Rudek, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Nature Cell Biology
|
June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression
Meng Zhang, Martin Sjöström, Xiekui Cui, et al.
Cancer Cell
|
June 28, 2002
Gene expression correlates of clinical prostate cancer behavior
Dinesh Singh, Phillip G Febbo, Kenneth Ross, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 28, 2009
The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model
John C Mavropoulos, W Cooper Buschemeyer, Alok K Tewari, et al.
The Journal of Urology
|
March 11, 2018
A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy
Amirali Salmasi, Jonathan Said, Alan W Shindel, et al.
Urology
|
January 3, 2016
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score
Timothy C Brand, Nan Zhang, Michael R Crager, et al.
European Urology Oncology
|
May 11, 2025
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate Cancer
Nicole Handa, Eric V Li, Jamie Michael, et al.
The EMBO Journal
|
January 7, 2005
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease
Jing Wang, Hiromi Iwasaki, Andrei Krivtsov, et al.
Journal of the National Cancer Institute
|
March 26, 2009
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer
Toshiro Migita, Stacey Ruiz, Alessandro Fornari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2008
NCCN Task Force Report: mTOR inhibition in solid tumors
Robert A Figlin, Elizabeth Brown, Andrew J Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2010
A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer
Andrew J Armstrong, George J Netto, Michelle A Rudek, et al.
Page
of 8